OR WAIT 15 SECS
Cantel Medical Corp. announces that the company has successfully completed the previously disclosed acquisition of NAMSA's Sterility Assurance Monitoring Products division. NAMSA's sterility assurance products will be integrated into the Crosstex product portfolio and reported in the Healthcare Disposables segment.
NAMSA's Sterility Assurance Monitoring Products division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Cantel's Healthcare Disposables segment.
Source: Cantel Medical Corp.